The greater glycated part of fructosamine is glycated albumin. It is measured using a simple and standardised enzymatic approach. Glycated albumin is being studied as a possible diabetes diagnostic tool. The glycated albumin test is a stronger indicator of short-term glycemic management than the A1C test. The glycated albumin assay, according to a 2016 research published in the National Center for Biotechnology Information (NCBI), is an effective technique to prevent diabetic complications and treat diabetic patients via early detection.
The global glycated albumin assay market was estimated to be valued at US$ 428.1 million in 2019, and is expected to exhibit a CAGR of 7.7% during the forecast period (2019-2027).
Request a sample copy of help grow your business @
https://www.coherentmarketinsights.com/insight/request-sample/1915
Increasing research and development activities, in order to develop novel diagnostic approach for diabetes and regulatory approval for such assay and tests are expected to be major factors driving growth of the global glycated albumin assay market over the forecast period
Increased research and development activities for the development of albumin assay tests are expected to fuel market expansion. Glycated albumin appears to have potential as a glycation index in diagnosing and screening diabetes parameters such as evaluating glycemic control status, especially for patients with end-stage renal disease (ESRD) and pregnant women as a predictor of diabetic complications, according to an article published in the Journal of Laboratory and Precision Medicine in September 2019. Furthermore, the category is predicted to rise due to an increase in the number of important companies in the market launching digital healthcare platforms. On the occasion of National Diabetes Month in November 2016, Epinex Diagnostics, Inc. released the ‘Am I Diabetic’ mobile phone app for iPhone and Android devices. The function of this app is to provide educational information and awareness about diabetes.
Rising adoption of inorganic growth strategies such as collaborations by key players, in order to develop and launch innovative glycated albumin assay is expected to drive the market growth. For instance, in July 2018, Ortho Clinical Diagnostics (Ortho) entered into collaboration with Diazyme Laboratories, Inc. to introduce its three new Microtip Partnership Assays (MSA) such as Glycated Serum Protein (GSP), Lipoprotein (a) (Lp (a)), and Cystatin C assays.
Launch of glycated hemoglobin assay for diagnosing diabetes mellitus is expected to hamper the global glycated albumin assay market growth
In the realm of clinical diagnosis, continuous research and development in assay technology has resulted in approvals and the introduction of better and more economical solutions. For example, Abbott’s Afinion HbA1c Dx assay, a quick point-of-care test for diabetes diagnosis, obtained FDA clearance in June 2019. The test provides precise and accurate HbA1c (glycated haemoglobin) findings. The Afinion HbA1c Dx assay, which can be used for both monitoring and diagnosis, is a complement to the Afinion HbA1c assay, which can only be used for monitoring. The introduction of such sophisticated glycated haemoglobin assays, on the other hand, is likely to slow the growth of the glycated albumin assay market throughout the projection period.
Get PDF Brochure of help grow your business @
https://www.coherentmarketinsights.com/insight/request-pdf/1915
Global Glycated Albumin Assay Market- Regional Analysis
On the basis of region, the global glycated albumin assay market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Because of the rising prevalence of diabetes in the region, North America is likely to have a dominating position in the market. According to the Centers for Disease Control and Prevention (CDC), over 100 million persons in the United States were diagnosed with diabetes or prediabetes in 2017. Furthermore, due to the availability of CE marked glycated albumin assay in Europe, the glycated albumin assay market in Europe is likely to develop significantly over the forecast period. For example, Asahi Kasei Pharma’s Lucica Glycated Albumin-L glycated albumin test is accessible in the European market. In 2015, the firm gained CE certification for Lucica Glycated Albumin-L.
Global Glycated Albumin Assay Market – Competitive Landscape
Key players operating in the global glycated albumin assay market include Asahi Kasei Corporation, Diazyme Laboratories, Inc., LifeSpan BioSciences, Inc., Biomatik Corporation, Abbexa Ltd., Geno Technology, Inc., DRG International, Inc., AMS Biotechnology (Europe) Limited, Abnova Corporation, Ethos Biosciences, Inc., Epinex Diagnostics Inc., DxGen Corp., and PathShodh Healthcare Private Limited.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Mergers and Acquisitions
- Regulatory Scenario
- Reimbursement Scenario
- PEST Analysis
- Market Dynamics
- Global Glycated Albumin Assay Market, By Product Type, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Human Glycated Albumin Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Animal Glycated Albumin Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Glycated Albumin Assay Market, By Application, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Prediabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Prediabetes
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Glycated Albumin Assay Market, By End User, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Glycated Albumin Assay Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Asahi Kasei Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Diazyme Laboratories, Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- LifeSpan BioSciences, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Biomatik Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbexa Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Geno Technology, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- DRG International, Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AMS Biotechnology (Europe) Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abnova Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ethos Biosciences, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Epinex Diagnostics Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- DxGen Corp.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- PathShodh Healthcare Private Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Asahi Kasei Corporation
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1915
Important Features and Key Highlights of the Market:-
- Detailed overview of market application and advantages.
- Understand the technologies support, Solution, Services. Understand the evaluation of dynamic growth.
- The in-depth market information of competitors, revenue, and cost structure.
- Strategies of key players, the competitive landscape.
- Historical data, current trend, and market volume and value.
- Industry restrains drivers and opportunities.
- product Development and offerings Key insights.
- Potential Application covers extensive analysis of emerging trends
Frequently Asked Questions
- What will the market size be in 2028 and at what rate will it grow?
- What are the Major growth driving factors for the global Glycated Albumin Assay market during the forecast period?
- What are the trends in the global Glycated Albumin Assay market?
- What are the key factors hampering the growth of the global Glycated Albumin Assay market?
- Which are the key players forming the competitive landscape?
- What is the current market size?
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837